Shares of Biodexa Pharmaceuticals Plc (LON:MTPH – Get Free Report) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 18 ($0.23) and traded as high as GBX 20 ($0.25). Biodexa Pharmaceuticals shares last traded at GBX 18 ($0.23), with a volume of 73,672 shares trading hands.
Biodexa Pharmaceuticals Stock Performance
The company has a market cap of £31.20 million, a price-to-earnings ratio of -21.95 and a beta of 1.22. The company has a current ratio of 5.28, a quick ratio of 5.28 and a debt-to-equity ratio of 9.52. The stock’s fifty day simple moving average is GBX 18 and its 200 day simple moving average is GBX 18.
Biodexa Pharmaceuticals Company Profile
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection.
Read More
- Five stocks we like better than Biodexa Pharmaceuticals
- What Are Dividend Challengers?
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- When to Sell a Stock for Profit or Loss
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- How to Calculate Options Profits
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Biodexa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodexa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
